Outcomes of Preoperative Opioid Usage in Hip Arthroscopy: A Comparison With Opioid-Naïve Patients


      To compare postoperative outcomes between opioid-naïve patients and patients with a history of preoperative opioid usage undergoing hip arthroscopy. The secondary purpose is to determine whether preoperative opioid users consumed more oral morphine milligram equivalents than opioid-naïve patients following surgery.


      This is a single-center, retrospective analysis comparing outcomes and postoperative opioid usage between patients with and without a history of preoperative opioid use. Inclusion criteria included patients ≥18 years, Tönnis grade 0 or 1, imaging consistent with FAI or labral pathology, and a diagnosis of symptomatic FAI requiring hip arthroscopy. Patient outcomes were compared throughout a 2-year follow-up using the modified Harris Hip Score, Nonarthritic Hip Score, and visual analog scale (VAS).


      In total, 17 patients were evaluated in each cohort. The mean age of the study cohort and control cohort were 52.0 ± 9.4 years and 51.2 ± 12.2 years, respectively. Female patients were 58.8% (n = 10) of both cohorts. Non-naïve patients had a lower preoperative Nonarthritic Hip Score (P = .05) and a greater VAS at their 6-month and 1-year (P < .001) postoperative visits. Naïve patients reported greater modified Harris Hip Scores 2 years postoperatively (P < .001). The study cohort was prescribed greater levels of oral morphine equivalents at the postoperative 1-year visit (P = .05). Opioid-naïve patients were more likely to reach minimally clinically important difference and patient acceptable symptom state of VAS at a faster rate. At the 2-year follow-up, 11.8% of opioid-naïve patients continued to take opioids compared with 58.8% from the non-naïve group for persistent hip pain (P < .001).


      We determined that preoperative opioid usage in patients undergoing hip arthroscopy is associated with inferior outcomes compared with opioid-naïve patients. In addition, preoperative opioid users are likely to continue the use of opioid medications postoperatively and at greater doses than opioid-naïve patients.

      Level of Evidence

      3, retrospective comparative study
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Arthroscopy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Rudd R.A.
        • Seth P.
        • David F.
        • Scholl L.
        Increases in drug and opioid-involved overdose deaths—United States, 2010-2015.
        MMWR Morb Mortal Wkly Rep. 2016; 65: 1445-1452
        • Morris B.J.
        • Mir H.R.
        The opioid epidemic: Impact on orthopaedic surgery.
        J Am Acad Orthop Surg. 2015; 23: 267-271
        • Volkow N.D.
        • McLellan T.A.
        • Cotto J.H.
        • Karithanom M.
        • Weiss S.R.
        Characteristics of opioid prescriptions in 2009.
        JAMA. 2011; 305: 1299-1301
        • Levy R.S.
        • Hebert C.K.
        • Munn B.G.
        • Barrack R.L.
        Drug and alcohol use in orthopedic trauma patients: A prospective study.
        J Orthop Trauma. 1996; 10: 21-27
        • Massey G.M.
        • Dodds H.N.
        • Roberts C.S.
        • Servoss T.J.
        • Blondell R.D.
        Toxicology screening in orthopedic trauma patients predicting duration of prescription opioid use.
        J Addict Dis. 2005; 24: 31-41
        • Anciano Granadillo V.
        • Cancienne J.M.
        • Gwathmey F.W.
        • Werner B.C.
        Perioperative opioid analgesics and hip arthroscopy: Trends, risk factors for prolonged use, and complications.
        Arthroscopy. 2018; 34: 2359-2367
        • Montgomery S.R.
        • Ngo S.S.
        • Hobson T.
        • et al.
        Trends and demographics in hip arthroscopy in the United States.
        Arthroscopy. 2013; 29: 661-665
        • Aprato A.
        • Jayasekera N.
        • Villar R.N.
        Does the modified Harris hip score reflect patient satisfaction after hip arthroscopy?.
        Am J Sports Med. 2012; 40: 2557-2560
        • Kemp J.L.
        • Collins N.J.
        • Roos E.M.
        • Crossley K.M.
        Psychometric properties of patient-reported outcome measures for hip arthroscopic surgery.
        Am J Sports Med. 2013; 41: 2065-2073
        • Jaeschke R.
        • Singer J.
        • Guyatt G.H.
        Measurement of health status. Ascertaining the minimal clinically important difference.
        Control Clin Trials. 1989; 10: 407-415
        • Tubach F.
        • Ravaud P.
        • Baron G.
        • et al.
        Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: The patient acceptable symptom state.
        Ann Rheum Dis. 2005; 64: 34-37
        • Bessette M.C.
        • Olsen J.R.
        • Mann T.R.
        • Giordano B.D.
        Intra-articular hip injections for lateral hip pain.
        J Hip Preserv Surg. 2014; 1: 71-76
        • Harris J.D.
        • Brand J.C.
        • Cote M.P.
        • Faucett S.C.
        • Dhawan A.
        Research pearls: The significance of statistics and perils of pooling. part 1: clinical versus statistical significance.
        Arthroscopy. 2017; 33: 1102-1112
        • Beck E.C.
        • Nwachukwu B.U.
        • Kunze K.N.
        • Chahla J.
        • Nho S.J.
        How can we define clinically important improvement in pain scores after hip arthroscopy for femoroacetabular impingement syndrome? Minimum 2-year follow-up study.
        Am J Sports Med. 2019; (363546519877861)
        • Chahal J.
        • Van Thiel G.S.
        • Mather 3rd, R.C.
        • et al.
        The patient acceptable symptomatic state for the modified Harris Hip Score and Hip Outcome Score among patients undergoing surgical treatment for femoroacetabular impingement.
        Am J Sports Med. 2015; 43: 1844-1849
        • Wolfson T.S.
        • Ryan M.K.
        • Begly J.P.
        • Youm T.
        Outcome trends after hip arthroscopy for femoroacetabular impingement: When do patients improve?.
        Arthroscopy. 2019; 35: 3261-3270
        • Levy D.M.
        • Kuhns B.D.
        • Chahal J.
        • Philippon M.J.
        • Kelly B.T.
        • Nho S.J.
        Hip arthroscopy outcomes with respect to patient acceptable symptomatic state and minimal clinically important difference.
        Arthroscopy. 2016; 32: 1877-1886
        • Stepan J.G.
        • London D.A.
        • Osei D.A.
        • Boyer M.I.
        • Dardas A.Z.
        • Calfee R.P.
        Perioperative celecoxib and postoperative opioid use in hand surgery: A prospective cohort study.
        J Hand Surg Am. 2018; 43: 346-353
        • Martin R.L.
        • Kivlan B.R.
        • Christoforetti J.J.
        • et al.
        Minimal Clinically important difference and substantial clinical benefit values for a pain visual analog scale after hip arthroscopy.
        Arthroscopy. 2019; 35: 2064-2069
        • Holman J.E.
        • Stoddard G.J.
        • Higgins T.F.
        Rates of prescription opiate use before and after injury in patients with orthopaedic trauma and the risk factors for prolonged opiate use.
        J Bone Joint Surg Am. 2013; 95: 1075-1080
        • Morris B.J.
        • Laughlin M.S.
        • Elkousy H.A.
        • Gartsman G.M.
        • Edwards T.B.
        Preoperative opioid use and outcomes after reverse shoulder arthroplasty.
        J Shoulder Elbow Surg. 2015; 24: 11-16
        • Westermann R.W.
        • Anthony C.A.
        • Bedard N.
        • et al.
        Opioid consumption after rotator cuff repair.
        Arthroscopy. 2017; 33: 1467-1472
        • Bedard N.A.
        • Pugely A.J.
        • Westermann R.W.
        • Duchman K.R.
        • Glass N.A.
        • Callaghan J.J.
        Opioid use after total knee arthroplasty: Trends and risk factors for prolonged use.
        J Arthroplasty. 2017; 32: 2390-2394
        • Dautremont E.A.
        • Ebramzadeh E.
        • Beck J.J.
        • Bowen R.E.
        • Sangiorgio S.N.
        Opioid prescription and usage in adolescents undergoing orthopaedic surgery in the united states: A systematic review.
        JBJS Rev. 2017; 5: e5
        • Stepan J.G.
        • Sacks H.A.
        • Lovecchio F.C.
        • et al.
        Opioid prescriber education and guidelines for ambulatory upper-extremity surgery: Evaluation of an institutional protocol.
        J Hand Surg Am. 2019; 44: 129-136
        • Soffin E.M.
        • Waldman S.A.
        • Stack R.J.
        • Liguori G.A.
        An evidence-based approach to the prescription opioid epidemic in orthopedic surgery.
        Anesth Analg. 2017; 125: 1704-1713
        • Liang Y.
        • Turner B.J.
        Assessing risk for drug overdose in a national cohort: Role for both daily and total opioid dose?.
        J Pain. 2015; 16: 318-325
        • Liang Y.
        • Turner B.J.
        National cohort study of opioid analgesic dose and risk of future hospitalization.
        J Hosp Med. 2015; 10: 425-431
        • Delbos A.
        • Boccard E.
        The morphine-sparing effect of propacetamol in orthopedic postoperative pain.
        J Pain Symptom Manage. 1995; 10: 279-286
        • Cunningham D.J.
        • Lewis B.D.
        • Hutyra C.A.
        • Mather R.C.
        • Olson S.A.
        Early recovery after hip arthroscopy for femoroacetabular impingement syndrome: A prospective, observational study.
        J Hip Preserv Surg. 2017; 4: 299-307